Tag Archives: biotechnology law

H.R. 1249 Voted Out Of Committee: No Grace Period For You!

Posted on April 18, 2011 by Warren Woessner

You may well be tired of hearing about the contending amendments, but I must note that the House version of the America Invents Act was voted out of Committee after being amended to reinstate the section of 102 that limits … Continue reading →

Posted in Patent Reform Legislation | Tagged , , , , , , , , , , , , | Leave a comment

PTO Issues Final Rule to Implement Prioritized Examination Track (Track I)

Posted on April 6, 2011 by Warren Woessner

The following is from the Schwegman, Lundberg & Woessner Newsletter, April 6, 2011. The Patent and Trademark Office on April 4, 2011, issued a final rule to implement prioritized examination upon an applicant’s request and payment of a $4,000 request … Continue reading →

Posted in USPTO Practice and Policy | Tagged , , , , , , , , , , | Leave a comment

Federal Court Hears Myriad Gene Case This Morning

Posted on April 5, 2011 by Warren Woessner

The following is a guest post from Ann McCrackin. I attended oral arguments at the CAFC on Monday for Association for Molecular Pathology v. Myriad Genetics, Inc.   The three-judge panel included Judge Bryson, Judge Lourie and Judge Moore.  Most of the … Continue reading →

Posted in Burden of Proof | Tagged , , , , , , , , , , , , , , , , | Leave a comment

One Step Towards an EJC Decision on the Patentability of Embryonic Stem Cells in Europe

Posted on March 31, 2011 by Warren Woessner

The following is a contribution from Verena Simpson PhD of Zacco Denmark A/S. On the 10 March 2011, the Advocates General of the European Court of Justice [ECJ] gave an opinion on the interpretation of Article 6(2)(c) of the Directive … Continue reading →

Posted in Stem Cells/Cloning | Tagged , , , , , | Leave a comment